CA Final · Direct Tax Laws & International Taxation · Transfer Pricing
Meridian Textiles Ltd's TPO has declared valid an option exercised by the assessee under section 166(9) for a similar transaction for a particular tax year. A reference for that transaction was also made by the AO under section 166(1) for the same year, before the TPO's declaration. What is the effect?
The reference is treated as if no reference had been made for that transaction. Under section 166(3), where the option is declared valid by the TPO, a reference made before or after the declaration has no effect for the transaction in that tax year.
- AThe reference stands and the declaration is ignored
- BBoth proceed in parallel and the higher price prevails
- CThe reference is treated as if no reference was made for such transactionCorrect
- DThe declaration is cancelled automatically
Explanation
Section 166(3) provides that where a reference is made, before or after the TPO's declaration of validity, for a tax year for which the option is declared valid, section 166(1) has effect as if no reference was made for that transaction. Option A is wrong because the declaration prevails.
Did you get it right without looking?
One question tells you little. A timed set on Transfer Pricing shows your real accuracy, how long you take and where you lose marks.
More Transfer Pricing questions
- For the tax year 2026-27, the TPO determined the arm's length price of Bharat Chemicals Ltd's import of raw material from its associated ent…
- Mahalakshmi Auto Ltd entered into an international transaction with its associated enterprise in a tax year. The Assessing Officer considers…
- Kaveri Pharma Ltd's assessment for a tax year is subject to a reference to the TPO under section 166. The limitation for completing the asse…
- For a tax year, the TPO declared valid Meridian Chemicals Ltd.'s option under section 166(9) for a particular international transaction. Lat…
- Kaveri Auto Ltd. had the arm's length price of a transaction determined by the TPO under section 166(6) for a tax year. The company wants th…
- Meru Pharma Ltd filed its report under section 172 disclosing only its royalty payment to an associated enterprise. During proceedings on a …